Hindustan Foods Ltd. · NSE:HNDFDS
Hindustan Foods — Q1 FY2027 Earnings Presentation
28 slides from Hindustan Foods's earnings presentation, Aug 4, 2026
Slide 1: Stock exchange filing letter for Earnings Presentation
HINDUSTAN FOODS LIMITED A Vanity Case Group Company A Government Recognised Two Star Export House Registered Office: Office No. 3, Level 2, Centrium, Phoenix Market City, 15, Lal Bahadur Shastri Road, Kurla (West), Mumbai, Maharashtra, India, 400 070. Email: business@thevanitycase.com, Website: www.
Slide 2: Hindustan Foods Limited Earnings Presentation
Hindustan Foods Limited Earnings Presentation Earnings August ’26 Presentation 1
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Hindustan Foods Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any secu
Slide 4: Business Overview (HOF)
= Business Overview (HOF)
Slide 5: Hindustan Foods at a Glance
Hindustan Foods at a Glance Built on Three Decades + of Manufacturing Excellence 42 12 states 15k#+ Factories, pan-India Manufacturing footprints Strong team 175 20+ 35+ yrs Acres of land bank Export countries Manufacturing experience Five Business Segments Home & Personal Care Food & Beverages Ice
Slide 6: Most Diversified Contract Manufacturer in India
Most Diversified Contract Manufacturer in India 1 Home & Personal Care 2 Ice Cream 3 Healthcare Beauty & Wellbeing Home Care House Insecticides Ice Cream Healthcare Skin Care & Hair Care, Toiletries & Toilet Cleaners, Floor & Surface Cleaners, Coils, Aerosols, Vaporizers, Refills, Ice Cream & Desser
Slide 7: Platform Built for Scale
Platform Built for Scale Scale That Touches Millions, Every Single Day Segment Home & Personal Care Food & Beverages Ice Cream Healthcare Footwear India's largest vertically India's leading home & personal India's largest independent India's trusted healthcare & Emerging footwear contract integrated
Slide 8: A Business Model Designed to Win
A Business Model Designed to Win Two Manufacturing Models, One Company Dedicated: Predictable Cash Flow Book Shared: The Organic Growth Lever • Manufacturing facility exclusively dedicated to a large scale and • Single manufacturing platform serving multiple customers and a single strategic customer
Slide 9: A Scalable, Trusted Manufacturing Platform
A Scalable, Trusted Manufacturing Platform Why the Biggest Brands Partner with HFL Trusted Manufacturing One-Stop & Flexible Innovation & Manufacturing Scale & Localization Partner & Brand Custodian Manufacturing Solutions Excellence • Among the largest and most • Three+ decades of contract • Compre
Slide 10: A Disciplined Approach to Capital Deployment
A Disciplined Approach to Capital Deployment Capital Allocation Strategy 18% ROCE investment threshold Capex follows signed contracts Projects are evaluated against an ~18% ROCE threshold, with New capacity is generally built against contracts already won, final investment decisions based on strateg
Slide 11: Growth Funded by Conviction (1/2)
Growth Funded by Conviction (1/2) Growing demand across all our operating segments is driving our investment strategy Home & Personal Care Food & Beverages s Ice cream India’s Home Care Market India’s Packaged Food Market India’s Ice Cream Market 2025 2030 Projection 2025 2034 Projection 2024 2030 P
Slide 12: Growth Funded by Conviction (2/2)
Growth Funded by Conviction (2/2) Growing demand across all our operating segments is driving our investment strategy Healthcare Footwear India's OTC Healthcare & Wellness Market India’s Footwear Market 2024 2030 Projection 2024 2030 Projection ₹47,000 Cr ₹98,000 Cr US$18.8 Bn US$37.9 Bn CAGR (2024–
Slide 13: Glimpse of HFL's Manufacturing Network (1/2)
Glimpse of HFL’s Manufacturing Network (1/2) 12
Slide 14: Glimpse of HFL's Manufacturing Network (2/2)
Glimpse of HFL’s Manufacturing Network (2/2) 13
Slide 15: Q1 FY27 Overview
m Q1 FY27 Overview (HUF) cs KEEP CALM & DO The more werd you are, A RE MAY THE THE DISHES ‘the more fun you are someone ae ea FORCE BE Mosquito Or usr use Morten 4QPE YOU ARE BACK OW OUR "EET SOON SC “OU 2AM FEED 4E
Slide 16: Q1FY27 Performance
Q1FY27 Performance Another Quarter of Consistent Execution, Results in Strong Earnings Delivery 18% 26% 33% YoY YoY YoY Revenue# EBITDA# Profit After Tax (PAT) Rs. 1,207 crores Rs. 106 crores Rs. 43 crores Net worth Cash and Cash Equivalents Net Debt to Equity Rs. 1,213 crores Rs. 67 crores 0.88x #
Slide 17: Key Business Highlights - Strong Execution Momentum; FY27 Outlook Reiterated
Key Business Highlights - Strong Execution Momentum; FY27 Outlook Reiterated CONSOLIDATED PROFIT AFTER TAX Rs. 42.8 cr Highest-Ever Quarterly Profit Rs. 340 Cr in New Project Wins Footwear: Cost & Wage Headwinds New manufacturing capacity signed during the financial Record consolidated performance w
Slide 18: Relentless Growth: Scaling Consistently – Q1FY27
Relentless Growth: Scaling Consistently – Q1FY27 Rs Cr REVENUE# 19% EBITDA# 29% 1,207.0 106.3 1,022.2 84.3 870.9 75.5 598.6 620.2 51.3 38.6 Q1FY23 Q1FY24 Q1FY25 Q1FY26* Q1FY27 Q1FY23 Q1FY24 Q1FY25 Q1FY26* Q1FY27 PROFIT BEFORE TAX^ PROFIT AFTER TAX 25% 30% 56.6 42.8 42.7 32.2 36.2 27.2 29.5 23.4 22.9
Slide 19: Operational Performance Overview: Dedicated vs Shared Manufacturing
Operational Performance Overview: Dedicated vs Shared Manufacturing Rs Cr FY25* FY26 Q1FY27 21% 26% 26% ▪ The company’s capital deployment in REVENUE^ recent years exemplifies a deliberate and 3,656 4,265 1,207 forward-leaning commitment to growth—strategically directed toward 74% 74% 79% scaling ca
Slide 20: Evolving Assets, Strategic Investments
Evolving Assets, Strategic Investments Significant Investments aimed at supporting future growth and scaling capacities across high-growth categories Rs Cr Momentum continues 2,346 340 1,854 152 Further strengthening its growth pipeline, the Board has authorized additional investments towards new ex
Slide 21: Q1FY27 Business Highlights - Home & Personal Care
Q1FY27 Business Highlights - Home & Personal Care HFL’s Project Update Operational Updates Project Capex Remarks • The new acquisition in Aurangabad for Personal Care with Aurangabad -Personal has fully been integrated, the production has been Care Facility Rs. 30 Crore Acquisition completed; produc
Slide 22: Q1FY27 Business Highlights - Food & Beverages
Q1FY27 Business Highlights - Food & Beverages HFL’s Project Update Project Capex Remarks Operational Updates Goa - Greek Yoghurt Rs. 60 Crore To be commercialised by Q3FY27 Manufacturing • Expanded the portfolio with a brownfield Greek Yogurt manufacturing facility in Goa, targeted to commence Auran
Slide 23: Q1FY27 Business Highlights - Ice Cream
Q1FY27 Business Highlights - Ice Cream HFL’s Project Update Project Capex Remarks Operational Updates Panipat Plant Rs. 225 Crore Commercialized in Q1FY27 • Delivered record Ice Cream production volumes across manufacturing facilities during the strong Panipat Plant Rs. 80 Crore To be commercialised
Slide 24: Q1FY27 Business Highlights – Healthcare
Q1FY27 Business Highlights – Healthcare HFL’s Project Update Project Capex Remarks Operational Updates Ayurvedic wellness • Initiated the Class 3 Medical Device certification manufacturing (Baddi) Rs. 25 Crore To be commercialized in Q3FY27 process at the Chennai facility for medicated plasters, sup
Slide 25: Q1FY27 Business Highlights – Footwear
Q1FY27 Business Highlights – Footwear HFL’s Project Update Project Capex Remarks Operational Updates Capacity expansion in Rs. 50 Crore In Progress • Strong orderbook for H2 FY27 North and South India • Expanding sole manufacturing facility in Tindivanam Capex Summary • The Footwear Division experie
Slide 26: Guidance 2027
Guidance 2027 PAT (Rs in Crores) H1 H2 200cr-220cr 52%-57% 149 H2FY27 +35% 115 54% 93 71 54% 48% 43%-48% 45 52% H1FY27 34 53% 46% 64% 52% 46% 48% 36% 47% FY21 FY22 FY23 FY24 FY25* FY26 FY27E Guidance Of Rs. 200-220 crores Momentum Profit After Tax for FY27 continues * FY25 numbers are restated 25
Slide 27: Consolidated Profit & Loss Statement – Q1FY27
Consolidated Profit & Loss Statement – Q1FY27 Particulars (Rs. Crs.) Q1 FY27 Q1 FY26* Y-o-Y Q4 FY26 Q-o-Q FY26 Total Revenue# 1,207.0 1,022.2 18% 1,120.9 8% 4,264.7 Cost of Goods Sold 936.4 801.0 869.1 3,327.8 Manufacturing and Operating Costs 72.8 53.8 61.6 226.5 Gross Profit 197.8 167.3 18% 190.3
Slide 28: Thank You
THANK YOU Company: Investor Relations Advisors: Hindustan Foods Limited Strategic Growth Advisors Pvt. Ltd. CIN: L15139MH1984PLC316003 CIN: U74140MH2010PTC204285 Vimal Solanki Rahul Agarwal / Aditya Parakh vimal.solanki@thevanitycase.com rahul.agarwal@sgapl.net/aditya.parakh@sgapl.net +91 98214 3886